HUTCHMED (China) (HMDCF) Current Deferred Revenue (2015 - 2026)

HUTCHMED (China) (HMDCF) has reported Current Deferred Revenue for 11 consecutive years, with $17.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 63.6% year-over-year to $17.1 million in Q2 2026; TTM through Jun 2026 was $17.1 million, a 63.6% decrease from a year earlier, with the FY2025 full-year figure at $31.4 million, changed N/A from the prior year.
• Current Deferred Revenue was $17.1 million for Q2 2026 at HUTCHMED (China), down from $31.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $52.3 million in Q2 2023 and troughed at $13.5 million in Q4 2022.
• A 5-year average of $34.9 million and a median of $39.1 million in 2025 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue retreated 2.72% in 2025 and tumbled 63.6% in 2026, its largest moves.
• Over 5 years, Current Deferred Revenue stood at $13.5 million in 2022, then jumped by 286.08% to $52.3 million in 2023, then fell by 7.87% to $48.2 million in 2024, then plunged by 34.76% to $31.4 million in 2025, then plunged by 45.72% to $17.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $17.1 million (Q2 2026), $31.4 million (Q4 2025), and $46.8 million (Q2 2025), per Business Quant data.